Beyond cancer, de novo truncating mutations in ASXL1, ASXL2, and ASXL3 have separately been identified in Bohring–Opitz, Bainbridge–Ropers, and related syndromes [68,69,70]. The gene discussed is ASXL1; the disease is cancer.